simplyStocks
Explore all companies →
Boston Scientific
BSX · NYSEMedical Devices
The economic chain
Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
Inputs &supplyAPIs, bioprocess, compone…Discovery &trialsR&D, partners, regulatorsProductsMedicines, therapies, dev…Payers &distributionWholesalers, PBMs, health…Providers &patientsHospitals, surgeons, pati…MATMaterials & componentsCMOContract manufacturersR&CTR&D & clinical trialsFDAFDA / EMABSXBoston ScientificCVCardiovascular devicesMSMedSurg devicesDSTDistributors & GPOsPAYPayers & governmentsHOSPHospitals & physiciansPTPatients
Company details
Market cap
~$71B
P/E ratio
~23×
Adj. EPS (FY25)
$3.06
GAAP EPS (FY25)
$1.94
Net income (FY25)
~$2.9B
Rev. growth
+18%
Revenue (FY25)
~$20B
Dividend
None
In plain English
Boston Scientific makes the tools that go inside the body — the Watchman implant that seals off a heart pocket to prevent stroke, the Farapulse pulsed-field ablation system that resets irregular heartbeats, and a huge catalogue of stents, catheters, scopes and urology devices. It has grown fastest by buying its way into new procedures, from Axonics in bladder control to its pending ~$14.5B takeover of Penumbra in clot removal.
In simple terms
What Boston Scientific really sells
Boston Scientific makes the tools that go inside the body — the Watchman implant that seals off a heart pocket to prevent stroke, the Farapulse pulsed-field ablation system that resets irregular heartbeats, and a huge catalogue of stents, catheters, scopes and urology devices. It has grown fastest by buying its way into new procedures, from Axonics in bladder control to its pending ~$14.5B takeover of Penumbra in clot removal.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.
Risk read
Moderate
SteadierMore speculative
Why this rating?